Deborah Smith
Psychiatric/Mental Health · Birmingham, ALNPI 1609650308
Payments from drug & device makers
Across 153 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$464
- Takeda Pharmaceuticals U.S.A., Inc.$428
- Corium, LLC$309
- Teva Pharmaceuticals USA, Inc.$241
- Neurocrine Biosciences, Inc.$220
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$209
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,86996%
- Education$1114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,980 in reported general payments places this provider in the 70th percentile of 378 psychiatric/mental health providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 15 | $120 |
| Trazodone Hcl | 12 | $106 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Birmingham
- Yuliya SpencerBirmingham$65K
- David CoffmanBirmingham$13K
- Tiffany WallerBirmingham$12K
- Kellie VaughnBirmingham$12K
- Amanda BoydBirmingham$10K
- Hannah KeslerBirmingham$9K
- Judy ClarkBirmingham$9K
- Jessica AdwellBirmingham$9K
- Pamela Kite TrullBirmingham$9K
- Lacey PodyBirmingham$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.